Steroid adduct formation with lens crystallins

Clinical and Experimental Optometry

Volumn 82, Issue 4, 1999, Pages 130-136

  Jobling, Andrew I ^a   Augusteyn, Robert C ^a  

^a NATIONAL VISION RESEARCH INSTITUTE   (Australia)

Author keywords

Crystallins; Glucocorticoids; Lens; Steroid cataract; Steroid protein adducts

Indexed keywords

EID: 0000407633     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.1999.tb06790.x     Document Type: Article

References (28)

1. Rubin B., Palestine AG. Complications of corticosteroid and immunosuppressive drugs. Int Ophthalmol Clin 1989; 29: 159–171.
2. Black RL, Oglesby RB, Von Sallmann L., Bunim JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960; 174: 150–155.
3. Crews SJ. Posterior subcapsular lens opacities in patients on long-term corticosteroid therapy. Brit Med J 1963; 5346: 1644–1647.
4. Valerio M. Les dangers de la cortisonothérapie locale prolongée. Bull Mem Soc Fr Ophthalmol 1963; 76: 572–580.
5. Abuekteish F., Kirkpatrick JN, Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy. Thorax 1995; 50: 674–676.
6. McGhee CNJ, Watson DG, Midley JM, Noble MJ, Dutton GN, Fern AI. Penetration of synthetic corticosteroids into human aqueous humor. Eye 1990; 4: 526–530.
7. Friedburg D., Kröner H., Rosenstiel L. In vivo action of corticosteroids on the guinea pig lens. Ophthal Res 1974; 6: 131–137.
8. Greiner JV, Kopp SJ, Glonek T. Dynamic changes in the organophosphate profile upon treatment of the crystalline lens with dexamethasone. Invest Ophthalmol Vis Sci 1982; 23: 14–22.
9. Harris JE, Gruber L. The electrolyte and water balance of the lens. ExpEye Res 1962; 1: 372–384.
10. Mayman CI, Miller D., Tijerina ML. In vitro production of steroid cataract in bovine lens. Part II: Measurement of sodium-potassium adenosine triphosphatase activity. Acta Ophthalmol 1979; 57: 1107–1116.
11. Bucala R., Fishman J., Cerami A. Formation of covalent adducts between Cortisol and 16 α-hydroxyestrone and protein: Possible role in the pathogenesis of Cortisol toxicity and systemic lupus erythematosus. Proc Natl Acad Sci USA 1982; 79: 3320–3324.
12. Manabe S., Bucala R., Cerami A. Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts. J Clin Invest 1984; 74: 1803–1810.
13. Bucala R., Gallati M., Manabe S., Cotlier E., Cerami A. Glucocorticoid-lens protein adducts in experimentally induced steroid cataracts. Exp Eye Res 1985; 40: 853–863.
14. Bucala R., Manabe S., Urban RC, Cerami A. Nonenzymatic modification of lens crystalline by prednisolone induces sulphydryl oxidation and aggregate formation: In vitro and in vivo studies. Exp Eye Res 1985; 41: 353–363.
15. Stevens VJ, Rouzer, CA, Monnier VM, Cerami A. Diabetic cataract formation: potential role of glycosylation of lens crystalline. Proc Natl Acad Sci USA 1978; 75: 2918–2922.
16. Lowry OH, Rosebrough, NJ, Far AL, Randall RJ. Protein measurement with the Folin-Phenol reagent. J Biol Chem 1951; 193: 265–275.
17. Pierscionek B., Augusteyn, RC. Protein distribution in concentric layers from single bovine lenses: changes with development and ageing. Curr Eye Res 1988; 7: 11–23.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 277: 680.
19. Augusteyn RC, Ghiggino KP, Putilina TP. Studies on the location of aromatic amino acids in α-crystallin. Biochim Biophys Acta 1993; 1162, 61–71.
20. Augusteyn RC, Hum, TP, Putilin T., Thomson JA. The location of sulphydryl groups in α-crystallin. Biochim Biophys Acta 1987; 915: 132–139.
21. Augusteyn RC. Protein modification in cataract; possible oxidative mechanisms. In: Duncan G., ed. Mechanisms of Cataract Formation in the Human Lens. London: Academic Press, 1981: 71–115.
22. Costagliola C., Iuliano G., Menzione M., Apponi-Battini G., Auricchio G. Effect of topical glucocorticoid administration on the protein and nonprotein sulphydryl groups of the rabbit lens. Ophthal Res 1987; 19: 351–356.
23. Miesbauer LR, Zhou X., Yang Z., Yang Z., Sun, Y., Smith, DL, Smith JB. Post-translational modifications of water-soluble human lens crystalline from young adults. J Biol Chem 269: 1994; 12494–12502.
24. Swamy MS, Abraham A., Abraham EC. Glycation of human lens proteins: preferential glycation of alpha A subunits. Exp Eye Res 1992; 54: 337–345.
25. White HE, Driessen HP, Slingsby C., Moss DS, Lindley PF. Packing interactions in the eye-lens. Structural analysis, internal symmetry and lattice interactions of bovine γIVα-crystallin. J Mol chem 1989; 207: 217–235.
26. Ortwerth BJ, Olesen PR, Krishna S., Prabhakara M. Chemical modification of alpha-crystallin. Exp Eye Res 1993; 56: 107–114.
27. Uribe M., Summerskill WHJ, Go VLW. Comparative prednisone and prednisolone concentrations following administration to patients with chronic active liver disease. Clin Pharmacol 1982; 7: 452.
28. Hook DW, and Harding JJ. Inactivation of glyceraldehyde 3-phosphate dehydrogenase by sugars, prednisolone-21-hemisuccinate, cyanate and other small molecules. Biochim Biophys Acta 1997; 1362: 232–242.